Format

Send to

Choose Destination
JAMA. 2016 Nov 22;316(20):2152. doi: 10.1001/jama.2016.16292.

Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.

Author information

1
Department of Medicine, University of California, San Francisco.
2
College of Physicians and Surgeons, Columbia University, New York, New York.
PMID:
27893125
DOI:
10.1001/jama.2016.16292
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center